Gordon L. Bundy

3.6k total citations · 2 hit papers
66 papers, 2.9k citations indexed

About

Gordon L. Bundy is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Gordon L. Bundy has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 23 papers in Organic Chemistry and 22 papers in Molecular Biology. Recurrent topics in Gordon L. Bundy's work include Inflammatory mediators and NSAID effects (24 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Nitric Oxide and Endothelin Effects (7 papers). Gordon L. Bundy is often cited by papers focused on Inflammatory mediators and NSAID effects (24 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Nitric Oxide and Endothelin Effects (7 papers). Gordon L. Bundy collaborates with scholars based in United States, Sweden and India. Gordon L. Bundy's co-authors include John E. Bleasdale, Laurel M. Sam, Robert J. Smith, Robert J. Smith, F.A. Fitzpatrick, Nirja Thakur, S Bunting, Robert R. Gorman, F.A. Fitzpatrick and Frank H. Lincoln and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Gordon L. Bundy

66 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

1990 566 citations Gordon L. Bundy et al. Journal of Pharmacology and Experimental Therapeutics profile →
Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness.

1990 526 citations Laurel M. Sam, Gordon L. Bundy et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Gordon L. Bundy

PHARM

PHYSI

CMN

Sharon Sadowski United States

L. S. Wolfe Canada

M. Michael Appleman United States

F.A. Fitzpatrick United States

George I. Drummond Canada

Donald J. Wolff United States

Klaus van Leyen United States

Joel G. Hardman United States

J Forn United States

Daigen Xu Canada

Sharon Sadowski United States

Gordon L. Bundy

1.5k ×1.2

619 ×1.0

PHARM

501 ×0.8

519 ×1.3

PHYSI

921 ×2.5

CMN

Citations per year, relative to Gordon L. Bundy Gordon L. Bundy (= 1×) peers Sharon Sadowski

Countries citing papers authored by Gordon L. Bundy

Since Specialization

Citations

This map shows the geographic impact of Gordon L. Bundy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon L. Bundy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon L. Bundy more than expected).

Fields of papers citing papers by Gordon L. Bundy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon L. Bundy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon L. Bundy. The network helps show where Gordon L. Bundy may publish in the future.

Co-authorship network of co-authors of Gordon L. Bundy

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon L. Bundy. A scholar is included among the top collaborators of Gordon L. Bundy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon L. Bundy. Gordon L. Bundy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Mark A., et al.. (2009). Chemotypic Coverage: A New Basis for Constructing Screening Sublibraries. Journal of Chemical Information and Modeling. 49(3). 531–542. 2 indexed citations

Lipton, Michael F., Gordon L. Bundy, Lee S. Banitt, et al.. (2002). Four Generations of Pyrrolopyrimidines. ChemInform. 33(42). 266–266. 1 indexed citations

Chin, Jia En, Cheryl A. Hatfield, G E Winterrowd, et al.. (1999). Preclinical Evaluation of Anti-inflammatory Activities of the Novel Pyrrolopyrimidine PNU-142731A, a Potential Treatment for Asthma. Journal of Pharmacology and Experimental Therapeutics. 290(1). 188–195. 19 indexed citations

Hall, Edward D., Paula K. Andrus, Sarah L. Smith, et al.. (1997). Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models. Journal of Pharmacology and Experimental Therapeutics. 281(2). 895–904. 58 indexed citations

Zhao, Zhiyang, Kenneth A. Koeplinger, Guy E. Padbury, et al.. (1997). Contribution of serum protein association to discrepancy between the in vivo and in vitro UDS results for 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843). Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 395(2-3). 119–126. 3 indexed citations

Hall, Edward D., Paula K. Andrus, Sarah L. Smith, et al.. (1996). Neuroprotective Efficacy of Microvascularly-Localized Versus Brain-Penetrating Antioxidants. PubMed. 66. 107–113. 49 indexed citations

Bundy, Gordon L., Donald E. Ayer, Lee S. Banitt, et al.. (1995). Synthesis of Novel 2,4-Diaminopyrrolo[2,3-d]pyrimidines with Antioxidant, Neuroprotective, and Antiasthma Activity. Journal of Medicinal Chemistry. 38(21). 4161–4163. 48 indexed citations

Fisher, Jed F., Allen W. Harrison, Gordon L. Bundy, et al.. (1991). Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties. Journal of Medicinal Chemistry. 34(10). 3140–3143. 91 indexed citations

Braughler, J. Mark, Philip S. Burton, R L Chase, et al.. (1988). Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation. Biochemical Pharmacology. 37(20). 3853–3860. 79 indexed citations

10.

Smith, Robert J., et al.. (1987). Arachidonic acid and 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid modulate human polymorphonuclear neutrophil activation by monocyte derived neutrophil activating factor. Biochemical and Biophysical Research Communications. 148(2). 636–645. 11 indexed citations

11.

Ciereszko, Leon S., Y. Gopichand, Francis J. Schmitz, William P. Schneider, & Gordon L. Bundy. (1985). Prostaglandin (15S)-PGA2 derivatives in the gorgonianPlexaura homomalla (Esper), formakükenthali Moser. Cellular and Molecular Life Sciences. 41(1). 37–38. 6 indexed citations

12.

Bundy, Gordon L., C. H. LIN, & John C. Sih. (1981). The synthesis of 2,3-dinorprostacyclin metabolites—a new approach to spirolactone hemiacetals. Tetrahedron. 37(25). 4419–4429. 15 indexed citations

13.

Fitzpatrick, F.A., Robert R. Gorman, & Gordon L. Bundy. (1978). An antiserum against 9,11-azo-15-hydroxy-prosta-5,13-dienoic acid recognises and binds prostaglandin endoperoxides. Nature. 273(5660). 302–304. 6 indexed citations

14.

Bundy, Gordon L., et al.. (1978). The synthesis of 15-deoxy-9,11-(epoxyimino)prostaglandinspotentthromboxane synthetase inhibitors. Tetrahedron Letters. 19(1). 41–44. 27 indexed citations

15.

Bundy, Gordon L., et al.. (1978). The synthesis of nitrogen-containing prostacyclin analogs. Tetrahedron Letters. 19(16). 1371–1374. 18 indexed citations

16.

Fitzpatrick, F.A. & Gordon L. Bundy. (1978). Hapten mimic elicits antibodies recognizing prostaglandin E2.. Proceedings of the National Academy of Sciences. 75(6). 2689–2693. 38 indexed citations

17.

Schneider, William P., Gordon L. Bundy, & Frank H. Lincoln. (1973). Preparation of prostaglandin E2 from Plexaura homomalla. Journal of the Chemical Society Chemical Communications. 254–254. 5 indexed citations

18.

Bundy, Gordon L., et al.. (1971). NOVEL PROSTAGLANDIN SYNTHESES. Annals of the New York Academy of Sciences. 180(1). 76–90. 67 indexed citations

19.

Marshall, James A., et al.. (1968). Studies relating to the synthesis of (+)-valeranone. The Journal of Organic Chemistry. 33(10). 3913–3922. 15 indexed citations

20.

Marshall, James A., et al.. (1965). The stereoselective synthesis of -valeranone. Tetrahedron Letters. 6(52). 4807–4815. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact